What's this? This is an unbiased just-the-facts news summary about Ebola, extracted from the original article by Newslines' contributors. To see the newsline of each topic, click the links below. Learn more


Bioweapon fears create serum

14 Aug, 2014

The San Diego-based Mapp Biopharmaceutical develops ZMapp with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) due to fears Ebola could be used as a bioweapon. ZMapp is made from two serums, MB-003 developed and ZMAb, made by Canadian company Defyrus Inc., and combined by Mapp Biopharmaceutical’s commercial arm LeafBio. MB-003 uses three chimera antibodies developed in mice, with human DNA spliced in, and grown in a genetically engineered indigenous Australian tobacco plant. ZMab was developed in a similar way.

View the full newsline: Ebola

Add your comments below...